Evidence map›Paper›PMID 33315875›Full record

ArticlePLoS neglected tropical diseases2020

Schistosoma haematobium infection is associated with alterations in energy and purine-related metabolism in preschool-aged children.

Derick N M Osakunor, Takafira Mduluza, Douglas Osei-Hyiaman, Karl Burgess, Mark E J Woolhouse, Francisca Mutapi

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Shared urinary metabolomic signatures as potential biomarkers for early intestinalCurrent research in parasitology & vector-borne diseases · 2026
    Article
  3. Article
  4. Article
  5. PNAS nexus · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Prevalence Mapping ofFrontiers in pediatrics · 2022
    Article
  11. Untargeted serum metabolomic profiling for early detection ofFrontiers in cellular and infection microbiology · 2022
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Derick N M OsakunorInstitute of Immunology & Infection Research, University of Edinburgh, Ashworth Laboratories, King's Buildings, Edinburgh, United Kingdom.ORCID 0000-0002-4853-5384
Takafira MduluzaBiochemistry Department, University of Zimbabwe, Mount Pleasant, Harare, Zimbabwe.
Douglas Osei-HyiamanLaboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, United States of America.ORCID 0000-0002-2725-5519
Karl BurgessCentre for Synthetic and Systems Biology, University of Edinburgh, CH Waddington Building, King's Buildings, Edinburgh, United Kingdom.ORCID 0000-0002-0881-715X
Mark E J WoolhouseUsher Institute, University of Edinburgh, Ashworth Laboratories, King's Buildings, Edinburgh, United Kingdom.ORCID 0000-0003-3765-8167
Francisca MutapiInstitute of Immunology & Infection Research, University of Edinburgh, Ashworth Laboratories, King's Buildings, Edinburgh, United Kingdom.ORCID 0000-0002-2537-3466
University of Edinburgh · GBTokyo Medical and Dental University · JPUniversity of Zimbabwe · ZW

Funding

Department of Health 16/136/33Wellcome TrustWellcome Trust 108061/Z/15/Z
6 · The paper itself

Abstract

Helminths are parasitic worms that infect over a billion people worldwide. The pathological consequences from infection are due in part, to parasite-induced changes in host metabolic pathways. Here, we analyse the changes in host metabolic profiles, in response to the first Schistosoma haematobium infection and treatment in Zimbabwean children. A cohort of 83 schistosome-negative children (2-5 years old) as determined by parasitological examination, guardian interviews and examination of medical records, was recruited at baseline. Children were followed up after three months for parasitological diagnosis of their first S. haematobium infection, by detection of parasite eggs excreted in urine. Children positive for infection were treated with the antihelminthic drug praziquantel, and treatment efficacy checked three months after treatment. Blood samples were taken at each time point, and capillary electrophoresis mass spectrometry in conjunction with multivariate analysis were used to compare the change in serum metabolite profiles in schistosome-infected versus uninfected children. Following baseline at the three-month follow up, 11 children had become infected with S. haematobium (incidence = 13.3%). Our results showed that infection with S. haematobium was associated with significant increases (>2-fold) in discriminatory metabolites, linked primarily with energy (G6P, 3-PG, AMP, ADP) and purine (AMP, ADP) metabolism. These observed changes were commensurate with schistosome infection intensity, and levels of the affected metabolites were reduced following treatment, albeit not significantly. This study demonstrates that early infection with S. haematobium is associated with alterations in host energy and purine metabolism. Taken together, these changes are consistent with parasite-related clinical manifestations of malnutrition, poor growth and poor physical and cognitive performance observed in schistosome-infected children.

Indexed as

Energy MetabolismSchistosoma haematobiumAnimalsAnthelminticsChild, PreschoolFemaleHumansMalePraziquantelPurinesSchistosomiasis haematobiaAnthelminticsPraziquantelPurines

Identifiers

PMID33315875
PMCPMC7735607
OpenAlexW3111718474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.